Sigyn Therapeutics announces the appointment of Annette Marleau, Ph.D. as Chief Scientific Officer, CSO, effective immediately. Dr. Marleau is a recognized thought leader in the development of therapeutic blood purification technologies to address cancer. Prior to joining Sigyn Therapeutics, Dr. Marleau was Chief Technology Officer at Immunicom, where she led R&D endeavors to establish blood purification candidates to treat cancer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SIGY: